Record ID | ia:butyrylcholinest0000unse |
Source | Internet Archive |
Download MARC XML | https://archive.org/download/butyrylcholinest0000unse/butyrylcholinest0000unse_marc.xml |
Download MARC binary | https://www.archive.org/download/butyrylcholinest0000unse/butyrylcholinest0000unse_meta.mrc |
LEADER: 03158cam 22005774a 4500
001 ocm51781667
003 OCoLC
005 20200522230531.0
008 030131s2003 enka b 001 0 eng
040 $aNLM$beng$cNLM$dUKM$dVAM$dCUS$dIWA$dBAKER$dYDXCP$dCGC$dOCLNG$dDEBSZ$dCRU$dBDX$dOCLCF$dHEBIS$dOCLCQ$dOCLCO
015 $aGBA3Y5578$2bnb
016 7 $a101191734$2DNLM
020 $a9781841842097
020 $a1841842095
035 $a(OCoLC)51781667
042 $apcc
050 14 $aQP609.C4$bB88 2003
060 00 $a2003 L-588
060 10 $aQU 136$bB987 2003
082 04 $a612.8042$221
245 00 $aButyrylcholinesterase :$bits function and inhibitors /$cEzio Giacobini, editor.
260 $aLondon ;$aNew York :$bMartin Dunitz,$c2003.
300 $ax, 181 pages :$billustrations ;$c25 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references and index.
505 0 $aCh. 1. Butyrylcholinesterase: its role in brain function -- Ch. 2. Butyrylcholinesterase function in the acetylcholinesterase knockout mouse -- Ch. 3. Butyrylcholinesterase in the normal and Alzheimer brain -- Ch. 4. Comparison of the structures of butyrylcholinesterase and acetylcholinesterase -- Ch. 5. Genetic variation in butyrylcholinesterase and the physiological consequences for acetylcholinesterase function -- Ch. 6. Butyrylcholinesterase: its selective inhibition and relevance to Alzheimer's disease therapy -- Ch. 7. Butyrylcholinesterase: studies with brain imaging --Ch. 8. Butyrylcholinesterase and cocaine -- Ch. 9. The preclinical pharmacology of butyrylcholinesterase -- Ch. 10. The role of butyrylcholinesterase in Alzheimer's disease -- Ch. 11. Butyrylcholinesterase K variant in Alzheimer's disease -- Ch. 12. Butyrylcholinesterase and dementia with Lewy bodies: involvement in symptom progression and treatment response -- Ch. 13. Butyrylcholinesterase: its use for prophylaxis of organophosphate exposure.
650 0 $aCholinesterases.
650 0 $aCholinesterase inhibitors.
650 0 $aCholinesterase genes.
650 0 $aCholinergic mechanisms.
650 12 $aButyrylcholinesterase$xphysiology.
650 22 $aButyrylcholinesterase$xtherapeutic use.
650 22 $aAlzheimer Disease$xphysiopathology.
650 22 $aCholinesterase Inhibitors$xpharmacology.
650 7 $aCholinergic mechanisms.$2fast$0(OCoLC)fst00858447
650 7 $aCholinesterase genes.$2fast$0(OCoLC)fst00858448
650 7 $aCholinesterase inhibitors.$2fast$0(OCoLC)fst00858449
650 7 $aCholinesterases.$2fast$0(OCoLC)fst00858456
650 7 $0(DE-588)4122098-5$0(DE-603)085398152$aCholinesterase$2gnd
700 1 $aGiacobini, Ezio.
938 $aBaker & Taylor$bBKTY$c179.95$d179.95$i1841842095$n0004150430$sactive
938 $aBrodart$bBROD$n00431265$c$179.95
938 $aTaylor & Francis$bTYFR$n1841842095
938 $aYBP Library Services$bYANK$n100334593
029 0 $aNLM$b101191734
029 1 $aAU@$b000025250971
029 1 $aYDXCP$b100334593
994 $aZ0$bP4A
948 $hNO HOLDINGS IN P4A - 80 OTHER HOLDINGS